Imagion Biosystems Ltd. (AU:IBX)
ASX:IBX
Australian Market
Holding AU:IBX?
Track your performance easily

Imagion Biosystems Ltd. (IBX) Financial Statements

6 Followers

Imagion Biosystems Ltd. Financial Overview

Imagion Biosystems Ltd.'s market cap is currently ―. The company's EPS TTM is AU$-0.193; its P/E ratio is -0.27; Imagion Biosystems Ltd. is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Dec 21Dec 20Dec 19Dec 18
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsAU$ 4.45MAU$ 13.39MAU$ 13.20MAU$ 3.40MAU$ 4.37M
Total AssetsAU$ 9.98MAU$ 14.12MAU$ 14.12MAU$ 4.87MAU$ 5.19M
Total DebtAU$ 4.60MAU$ 46.02KAU$ 660.98KAU$ 876.78KAU$ 54.52K
Net DebtAU$ 158.27KAU$ -13.35MAU$ -12.54MAU$ -2.52MAU$ -4.31M
Total LiabilitiesAU$ 5.30MAU$ 809.88KAU$ 1.21MAU$ 1.90MAU$ 1.32M
Stockholders EquityAU$ 4.68MAU$ 13.31MAU$ 12.91MAU$ 2.97MAU$ 3.87M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in AUD

Imagion Biosystems Ltd. Earnings and Revenue History

Imagion Biosystems Ltd. Debt to Assets

Imagion Biosystems Ltd. Cash Flow

Imagion Biosystems Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis